We report a case of transapical mitral valve-in-valve implantation for a deteriorated bioprosthesis using the SAPIEN 3. Our patient, a 79-year-old man, with a history of mitral valve replacement 10 years before, presented with acute dyspnea due to mitral valve dysfunction. He was successfully treated with transapical implantation and had an uneventful recovery. Our case demonstrates the feasibility of using SAPIEN 3 in treating degenerated bioprosthetic mitral valves.
BourguignonT., Bouquiaux-StabloA.L., LoardiC.Very late outcomes for mitral valve replacement with the Carpentier-Edwards pericardial bioprosthesis: 25-year follow-up of 450 implantations. J Thorac Cardiovasc Surg.2014; 148: 2004–2011.
2.
JamiesonW.R., GudasV.M., BurrL.H.Mitral valve disease: if the mitral valve is not reparable/failed repair, is bioprosthesis suitable for replacement?Eur J Cardiothorac Surg.2009; 35: 104–110.
CheungA., WebbJ.G., BarbantiM.5-year experience with transcatheter transapical mitral valve-in-valve implantation for bioprosthetic valve dysfunction. J Am Coll Cardiol.2013; 61: 1759–1766.
5.
CheungA., WebbJ.G., WongD.R.Transapical transcatheter mitral valve-in-valve implantation in a human. Ann Thorac Surg.2009; 87: e18–e20.
6.
SeiffertM., FranzenO., ConradiL.Series of transcatheter valve-invalve implantations in high-risk patients with degenerated bioprostheses in aortic and mitral position. Catheter Cardiovasc Interv.2010; 76: 608–615.
7.
WilbringM., AlexiouK., TugtekinS.M.Transapical transcatheter valve-in-valve implantation for deteriorated mitral valve bioprostheses. Ann Thorac Surg.2013; 95: 111–117.
8.
BinderR.K., Rodés-CabauJ., WoodD.A.Transcatheter aortic valve replacement with the SAPIEN 3: a new balloon-expandable transcatheter heart valve. JACC Cardiovasc Interv.2013; 6: 293–300.
9.
WilbringM., AlexiouK., TugtekinS.M.Transcatheter valve-in-valve therapies: patient selection, prosthesis assessment and selection, results, and future directions. Curr Cardiol Rep.2013; 15: 341.
